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Background: Amino acid substitutions I22V and L72S in the prM protein of West Nile virus Kunjin strain (WNVKUN)
were previously shown to enhance virus secretion and virulence, but a mechanism by which this occurred was not
determined.
Findings: Using pulse-chase experiments followed by co-immunoprecipitation with anti-E antibody, we
demonstrated that the I22V and L72S substitutions enhanced prM/E heterodimerization for both the E-glycosylated
and E-unglycosylated virus. Furthermore, analysis of secreted particles revealed that I22V and L72S substitutions also
enhanced nucleocapsid incorporation.
Conclusions: We have demonstrated mechanistically that improved secretion of virus particles in the presence of I22V
and L72S substitutions was contributed by more efficient prM/E heterodimerization.
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The pre-membrane (prM) and envelope (E) proteins
together form the outer structure of West Nile virus
(WNV) particles [1,2]. The outer envelope encases a
nucleocapsid, consisting of capsid (C) proteins and a
single-stranded positive-sensed RNA genome. Incorpor-
ation of nucleocapsid into virus particles was proposed
to be regulated by coordinated cleavages at the C-prM
junction [3]. The prM protein is required to chaperone
E [4,5], is essential for viral particle formation [6,7], and
prevents premature fusion during virus egress [8]. Muta-
genesis studies have led to the discovery of motifs and
specific amino acid residues within prM that encode im-
portant functions such as virus particle assembly [9-11],
prM/E heterodimerisation [12], and virus particle secre-
tion [13,14].* Correspondence: roy.hall@uq.edu.au
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unless otherwise stated.We have previously characterised two amino acid sub-
stitutions in Kunjin virus (WNVKUN) prM, which when
substituted with the corresponding residues of the viru-
lent American New York 1999 strain (WNVNY99) (I22V
and L72S) resulted in a more stable antigenic structure
of the prM protein (analysed using conformational-
dependent monoclonal antibody), and promoted efficient
secretion of prME and virus particles, as well as in-
creased virulence in weanling mice [15]. In order to
identify potential mechanism by which the I22V and
L72S prM mutations (prM22/72) exert their effect (s),
two previously generated viruses (WNVKUN strain
MRM61C, encoding unglycosylated E) with and without
the prM22/72 mutations were utilized [15]. Taking into
account that E-glycosylation was shown to affect the ef-
ficiency of viral particle secretion and virulence [16,17],
two additional E-glycosylated mutant viruses (with or
without the prM22/72 mutations) were also generated
for this study (Figure 1A). The viruses were generated as
previously described [15], and passage 2 virus stockshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Generation and characterisation of prM22/72 mutant viruses. A) Schematics of the viruses constructed for this study, shown with or
without E-glycosylation and/or prM22/72 mutations. B) Plaque morphology of recombinant viruses were performed on Baby Hamster Kidney cell
monolayer, fixed and stained 4 days post infection with crystal violet.
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tions were stably maintained. The E-glycosylated viruses
formed larger and clearer plaques compared to the E-
unglycosylated viruses. Slightly larger plaques were
observed for the ECHO (−) prM22/72 (0.92 ± 0.17 mm,
n=10) mutant virus compared to the wt ECHO (−) virus
(0.52 ± 0.15 mm, n=10) (Figure 1B). This suggested that
the enhanced virulence of prM22/72 the mutants were
possibly mediated by increased efficiency in virus spread
or cytopathic effects in cell culture. We therefore
focused on investigating the mechanistic roles of prM
protein in the formation of virus particles. Firstly, to
characterise prM/E heterodimerisation, Vero cells were
infected with respective viruses at MOI=0.1, and at
18 hours post infection cells were starved in methio-
nine/cysteine free media for 30 mins, and then metabol-
ically labelled with 35S-methionine/cysteine for 5 mins
(pulse). Cell lysates were then collected at chase times of
0, 3, 6 and 20 mins, and co-precipitation of prM was
performed using anti-E monoclonal antibody (3.91D)
coated onto Protein G Dynabeads (Invitrogen). The
3.91D antibody was chosen because it displays strong
binding to E protein under reducing conditions on
Western blot, indicating that folding of E is not a re-
quirement for binding [18]. Furthermore, it has been
mapped to bind in a region in domain III of E (Clarke
et al., unpublished results) which is distal to the pr/E
interaction sites based on the dengue virus prM/E crys-
tal structure [8]. The amounts of co-precipitated prM
and E were measured as corresponding integrated dens-
ities determined by ImageJ image processing software
(http://imagej.nih.gov/ij/) from two independently con-
ducted experiments, and expressed as prM to E ratio.
The prM to E ratio normalizes the amount of prM in
relation to E, allowing the accurate quantification of
prM/E heterodimerisation efficiency at each time point
regardless of E content. prM co-precipitation was de-
tected between 0–3 mins chase for E-CHO (−) prM22/
72, and only after 6 mins for E-CHO (−) (Figure 2A).More impressively, prM co-precipitation was already
detected at 0 time chase for E-CHO (+) prM22/72, most
likely heterodimerising with E during the 5 mins pulse
phase, while prM co-precipitation for E-CHO (+) was
detected starting from 3 mins chase (Figure 2B). The data
indicated that for both E-glycosylated and E-unglycosylated
viruses, prM/E heterodimerisation was more rapid
with the introduction of the prM I22V and L72S muta-
tions. This could likely be attributed to a more stable
prM antigenic structure [15], promoting rapid folding
of prM and subsequent heterodimerisation with E
protein.
To further investigate how rapid prM/E heterodimeri-
sation affected secretion of virus particles, Vero cells
were infected at MOI=1, and at 18 hours post infection,
were labelled with 35S-methionine/cysteine for 6.5 hours.
The metabolically labelled virus particles secreted into
the culture media were purified using the 3.91D-coated
Protein G Dynabeads. To prevent the disruption of the
virus particles, washes were carried out using phosphate
buffered saline without Tween-20. The precipitated virus
particles were resuspended in NuPAGE LDS Sample
Buffer (Novex) and resolved by SDS-PAGE using a
NuPAGE 4–12% Bis-Tris Protein Gel (Novex), followed by
exposing radiolabelled gel to phosphorscreen (Figure 3A).
Integrated densities of the labelled E, prM, C and M bands
were measured using ImageJ image processing software
from two independently conducted experiments. Firstly,
we investigated if the prM22/72 mutations affected furin
cleavage of prM (present in immature particles) to M
(present in mature particles) by calculating the integrated
density ratios of the prM to M bands. No significant dif-
ferences between the viruses were observed, suggesting
that furin cleavage of prM was not affected (Figure 3B).
This was expected considering that the prM22/72 muta-
tions lie outside of the predicted furin cleavage site, and
have been previously shown not to affect furin cleavage
using an in vitro furin cleavage assay [15]. The uniform
prM to M ratios also served to positively validate our
Figure 2 prM22/72 mutations enhanced prM/E heterodimerization. Vero cells were infected with A) unglycosylated and B) glycosylated viruses
at MOI=0.1, and 18 hours later were labelled for 5 mins and chased at 0, 3, 6, and 20 mins. Metabolically-labelled prM was co-precipitated with E
using anti-E antibody (3.91D), resolved by SDS-PAGE and exposed on a phosphorscreen. ImageJ analysis was performed to determine the
integrated densities of bands and calculated as a prM:E ratio. Bar graphs represent data from two independent experiments. Statistical analysis
was performed using t-test comparing between samples at each timepoint. * P≤ 0.05, ns – not significant.
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of C to E ratio revealed a significantly increased rate of
nucleocapsid incorporation by the prM22/72 mutant
viruses compared to wt prM viruses (Figure 3C), sug-
gesting that a more rapidly folding prM protein could
potentially incorporate nucleocapsid into virions more
efficiently.Figure 3 Characterisation of secreted virus particles. A) Vero cells were infe
6.5 hours. Culture supernatant was collected and purified by immunoprecip
of the integrated densities of prM to M bands indicating maturation status
E bands indicate the efficiency of nucleocapsid incorporation into virions. B
Statistical analysis was performed by One-way ANOVA with multiple compConclusion
To date, there have been three separate studies investigat-
ing residues in WNV prM involved with particle forma-
tion and secretion [11,14,15]. Calvert et al. [14] showed
that prM T20 and K31 residues were important for prME
particle secretion, with a significant inhibition of prM/E
heterodimerisation by the T20D mutation. Although K31cted at MOI=1 and at 18 hours post infection, were pulsed for
itation using anti-E mAb (3.91D) and resolved on SDS-PAGE. B) Ratio
of secreted virus particles. C) Ratio of the integrated densities of C to
ar graphs represent data from two independent experiments.
arisons. ** P≤ 0.01, *** P≤ 0.001.
Figure 4 prM residues involved in particle assembly and secretion on the prM/E crystal structure. (PDB: 3C6D, pr in green, E in grey, adapted
from Li et al., [8]) A) Top view of prME spike showing prM residues I22 (red), T20 and K31 (yellow). B) Side view of prM showing I22, T20 and K31
on the same plane position on the top of the prM/E trimeric spike. C) Side view showing residues L72 (blue) and Y78 (magenta) facing the prM
and E interface.
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an increased accumulation of prME proteins was detected
in the endoplasmic reticulum (ER) to Golgi interfaces,
demonstrating its role in prME particle secretion [14]. We
have previously shown using recombinant V5His-tagged
WNV prM, that the I22V mutation enhanced prM export
out of the ER [15]. We similarly detected increased pres-
entation of prM on the surface of transfected cells when
the I22V mutation was introduced [15]. Interestingly, on
the crystal structure of Dengue prM, I22 residue clusters
with the T20 and K31 residues, with all three residues sit-
ting on a plane at the apex of the prME trimeric spike
(Figures 4A & B). Due to the surface-exposed positions of
T20 and K31 residues, it was suggested by Calvert et al.
[14], that this region of prM could be involved in protein
trafficking (and hence particle secretion) through inter-
action with host cellular factors [19].
In a study by Tan et al. [11], the Y78 residue in WNV
prM was demonstrated to be critical for virus particle
assembly. The Y78A mutant produced no particles or
virus-induced cellular structures in cells despite readily
detectable intracellular E protein. However, prM/E het-
erodimerisation was not disrupted by the Y78A muta-
tion, which suggests that the defect in the virus particle
assembly process could be due to disruption of the
higher-order structural re-arrangement of prM/E heterodi-
mers [11]. Notably, we previously reported that a mutation
in a nearby residue, L72S, had a significant impact on the
antigenic structure of WNV prM [15]. We demonstrated
that recognition of L72-prM, by the conformation-
dependent monoclonal antibody P10F8, was only suc-
cessful when co-expressed with E, while S72-prM was
structurally stable and recognised by P10F8, independ-
ent of co-expression with E [15]. Interestingly, L72
residue is positioned on the same side of prM protein
as Y78, and both are found at the interface between
prM and E (Figures 4B & C) [11]. Based on these find-
ings, we hypothesize that the region spanning residues72 to 78 is likely to be important for stabilizing the
overall structure of prM in the absence of E, or the
higher-order prM/E heterodimeric structures.
In our investigations, we demonstrated that the prM22/
72 mutations resulted in enhanced incorporation of capsid
protein into secreted virions. This finding was unantici-
pated as prM and E ectodomains are located on opposite
sides of the membrane in relation to the capsid protein.
Mutations in the prM ectodomain should therefore not
have a direct effect on capsid function. In accordance, the
production of smaller prME particles (corresponding to
virus-like particles) and larger prME particles (corre-
sponding to virions) in the absence of capsid [20] suggests
that prME formation and capsid assembly are independ-
ent processes. However, Lobigs et al. [3,21] have elegantly
demonstrated that co-ordinated cleavages between C-prM
influences the effectiveness of nucleocapsid incorporation
into nascent virions, and that delayed signalase cleavage of
prM in the ER lumen is critical for nucleocapsid incorpor-
ation [22], highlighting the possibility that the I22V and
L72S ectodomain substitutions may somehow affect the
viral NS2B/NS3 protease and host signalase co-ordinated
cleavage events that occur closer to the membrane. An-
other possible mechanism could be due to the increased
affinity of prM for E, and by association of C with prM (in
the uncleaved form), this could rapidly draw more capsid
molecules into the assembly site, before the C-prM cleav-
ages are completed.
In conclusion, our findings revealed that the I22V and
L72S mutations in WNVKUN prM significantly enhanced
the heterodimerisation of prM and E proteins. Addition-
ally, we showed that these mutations in prM enhance
nucleocapsid incorporation into virions by an as yet un-
known mechanism.
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